Immunoglobulin A: A next generation of therapeutic antibodies?

MAbs. 2011 Jul-Aug;3(4):352-61. doi: 10.4161/mabs.3.4.16092. Epub 2011 Jul 1.

Abstract

Although immunoglobulin (Ig) A is commonly recognized as the most prevalent antibody subclass at mucosal sites with an important role in mucosal defense, its potential as a therapeutic monoclonal antibody is less well known. However, IgA has multifaceted anti-, non-, and pro-inflammatory functions that can be exploited for different immunotherapeutical strategies, which will be the focus of this review.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunity, Mucosal
  • Immunoglobulin A / chemistry
  • Immunoglobulin A / immunology
  • Immunoglobulin A / therapeutic use*
  • Immunotherapy / methods
  • Infections / therapy*
  • Models, Molecular
  • Neoplasms / therapy*
  • Receptors, IgE / immunology*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin A
  • Receptors, IgE